Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» early breast cancer
early breast cancer
Novartis gears up for label expansion for Kisqali with Phase III results
Clinical Trials Arena
Mon, 12/11/23 - 11:18 am
Novartis
Kisqali
FDA
clinical trials
early breast cancer
breast cancer
ASCO preview: Merck's Keytruda, Novartis' Kisqali face their moment of truth in early-stage cancers
Fierce Pharma
Thu, 05/25/23 - 08:33 pm
ASCO 2023
Merck
Keytruda
Novartis
Kisqali
non-small cell lung cancer
early breast cancer
Eli Lilly's Verzenio snags first-in-class FDA approval for early breast cancer. But limited label poses a challenge
Fierce Pharma
Wed, 10/13/21 - 11:07 am
Eli Lilly
Verzenio
FDA
early breast cancer
breast cancer
Look for Eli Lilly's Verzenio to hit $4.6B, thanks to early breast cancer win: analyst
Fierce Pharma
Tue, 03/2/21 - 12:12 pm
Eli Lilly
Verzenio
breast cancer
early breast cancer
